What are Platelet Aggregation Devices?
Platelet aggregation is the procedure in which the platelets are clomped together in the blood which leads to the formation of a thrombus or clot. The devices involved in the aggregation of platelets are termed as platelet aggregation devices market. The aggrometers, one of the medical device used in platelet aggregation, works against the clotting, to further stop the clot formation. This process is used for the diagnosis and identification of the defects in platelet functions.
What is the Platelet Aggregation Devices Market?
The global platelet aggregation devices market was valued at USD 365.54 million in 2021, growing at a CAGR of 7.85% during the forecast period from 2022 to 2027 to reach USD 573.25 million by 2027. The platelet aggregation devices market is witnessing positive growth owing to various factors such as the rising prevalence of cardiovascular, hematological, and other target disorders and surging burden of geriatric population across the globe. Further, technological advancements in platelet aggregometers, for instance accurate and automatic testing of platelets and other advancements will increase the demand of the device in the forthcoming years. Additionally, the rise in the number of industry-academia collaborations and clinical studies in the healthcare industry will also contribute in the growth of platelet aggregation devices market. Also, the increasing regulatory approvals and launches across the globe will further increase the overall growth of the platelet aggregation devices market. Therefore, the market for platelet aggregation devices market is estimated to grow at a significant CAGR during the forecast period from 2022 to 2027.
Know which Platelet Aggregation Devices is expected to score the touchdown first @ Platelet Aggregation Devices Market Size
What is the Platelet Aggregation Devices Market Dynamics?
One of the main driver for the platelet aggregation devices market is the increasing figures of bleeding and haematological disorders. For instance, the National Organization for Rare Disorders (NORD) stated in a latest study the incidence of adult Immune thrombocytopenia (ITP) in the United States was roughly estimated to be 3.3 per 100,000/year. Also, the prevalence od ITP was reported to be 9.5 per 100,000. Further, in a study done by the Maryland Health Care Commission (2021), the prevalence of ITP was estimated to be 9.5 per 100,000 children ages 1-5, 7.3 per 100,000 in children ages 6-10, and 4.1 per 100,000 in children of ages 11-14, in 2021, in the United States.
COVID-19 Impact on the Platelet Aggregation Devices Market
The COVID-19 pandemic has negatively impacted the market for platelet aggregation devices market. The outbreak of the pandemic led to the cancellation of outpatient visits and the suspension of non-emergency hospitals and surgical procedures for chronic disorders such as cancers, diabetes, cardiovascular disorders, and others. Moreover, the number of diagnostic tests many disorders were reduced as the priority was given to the covid-19 testing. Further, due to imposition of strict lockdown rules the manufacturing of the devices was ceased. However, vaccine development of COVID-19 has produced the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services, diagnostic tests, and surgical procedures for the treatment and management of various diseases ultimately increasing the demand of platelet aggregation devices market, thereby bringing the demand for device on track in the platelet aggregation devices market.
Learn more for Platelet Aggregation Devices Market Research Report @ Platelet Aggregation Devices Market Share
What are the drivers for the Platelet Aggregation Devices market?
The platelet aggregation devices market is observing an affirmative market growth owing to the factors such as rising prevalence of cardiovascular, haematological, and other target disorders, surging burden of geriatric population, technological advancements in platelet aggregometers, rise in the number of industry-academia collaborations and clinical studies, and the upsurge in the regulatory approvals for platelet aggregation devices market.
Who are the Platelet Aggregation Devices Market Companies?
Some of the key market players operating in the platelet aggregation devices market include F. Hoffmann-La Roche Ltd, Werfen, Drucker Diagnostics, Haemonetics Corporation, Sienco, Inc., BIO/DATA CORPORATION, AggreDYNE, Siemens Healthcare Private Limited, Chrono-log Corporation, Grifols, S.A., Helena Laboratories Corporation., SENTINEL. Sysmex Corporation, Matis Medical Inc., Elektronik GmbH & Co., and others.
For further information of the Platelet Aggregation Devices market report @ Platelet Aggregation Devices Market Forecast
Which region has the highest share in Platelet Aggregation Devices Market?
North America is expected to dominate the global platelet aggregation devices market. Factors contributing to the growth are the rising number of cardiovascular surgeries, rising number of orthopaedic, urological, bleeding, and disorders, escalating burden of geriatric patients, and others which are contributing to the growth of the platelet aggregation devices market in the North America region.
Latest Market Research Reports 2022 by DelveInsight
- Erosive Hand Osteoarthritis Market
- CXCR Inhibitors Market
- Stem Cell Market
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Market
- Oncolytic Virus Cancer Therapy Pipeline
- Surgical Sealant Market
- Superficial Punctate Keratitis
- Medical Marijuana Market
- Immune Checkpoints Activators Market
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
Contact Us
Yash Bhardwaj
info@delveinsight.com
